Protein Engineering vol. 4 no. 2 pp. 191-198, 1990
© 1990 Oxford University Press
RESEARCH-ARTICLE |
Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis
Gaubius Institute TNO PO Box 612, 2300 AP Leiden, The Netherlands 1The Upjohn Company, Molecular Biology Department Kalamazoo, MI, USA
2To whom correspondence should be addressed
Modification of glutamic and aspartic acid residues of tissue-type plasminogen activator (t-PA) with 1-ethyl-3(3-dimethyl-aminopropyl)-carbodiimide leads to a decrease in affinity for lysine and fibrin, to a decrease of plasminogen activation activity in the presence of a fibrin mimic, but leaves amidolytic activity and plasminogen activation without fibrin mimic unaffected. Experiments with kringle-2 ligands and a deletion mutant of t-PA (K2P) suggests that glutamic or aspartic acid residues in K2 of t-PA are involved in stimulation of activity, lysine binding and fibrin binding. Mutant t-PA molecules were constructed by site-directed mutagenesis in which one or two of the five aspartic or glutamic acid residues in K2 were changed to asparagine or glutamine respectively. Mutation of Asp236 and/or Asp238 leads to t-PA molecules with 3- to 4-fold lower specific activity in the presence of fibrin mimic and having no detectable affinity for lysine analogs. However, fibrin binding was not influenced. Mutation of Glu254 also leads to a 3- to 4-fold lower activity, but to a much smaller reduction of lysine or fibrin binding. Residues Asp236 and Asp238 are both essential for binding to lysine derivatives, while Glu254 might be involved but is not essential. Residues Asp236, Asp238 and Glu254 are all three involved in stimulation of activity. Remarkably, mutation of residues Asp236 and/or Asp238 appears not to influence fibrin binding of t-PA whereas that of Glu254 does.
Keywords: fibrin binding/kringle/lysine binding/mutant/tissue-type plasminogen activator
Received June 4, 1990; accepted August 30, 1990.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-L. Zhang, L. Hervio, L. Strandberg, and E. L. Madison Distinct Contributions of Residue 192 to the Specificity of Coagulation and Fibrinolytic Serine Proteases J. Biol. Chem., March 12, 1999; 274(11): 7153 - 7156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. A. Quax, J. M. Grimbergen, M. Lansink, A. H. F. Bakker, M.-C. Blatter, D. Belin, V. W. M. van Hinsbergh, and J. H. Verheijen Binding of Human Urokinase-Type Plasminogen Activator to Its Receptor : Residues Involved in Species Specificity and Binding Arterioscler Thromb Vasc Biol, May 1, 1998; 18(5): 693 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tachias and E. L. Madison Variants of Tissue-type Plasminogen Activator That Display Extraordinary Resistance to Inhibition by the Serpin Plasminogen Activator Inhibitor Type 1 J. Biol. Chem., June 6, 1997; 272(23): 14580 - 14585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Ke, K. Tachias, D. Lamba, W. Bode, and E. L. Madison Identification of a Hydrophobic Exosite on Tissue Type Plasminogen Activator That Modulates Specificity for Plasminogen J. Biol. Chem., January 17, 1997; 272(3): 1811 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. F. Bakker, E. J. D. Weening-Verhoeff, and J. H. Verheijen The Role of the Lysyl Binding Site of Tissue-type Plasminogen Activator in the Interaction with a Forming Fibrin Clot J. Biol. Chem., May 26, 1995; 270(21): 12355 - 12360. [Abstract] [Full Text] [PDF]
|
|